Maryland 2026 Regular Session

Maryland House Bill HB0838

Caption

State Board of Pharmacy - Prescriber-Pharmacist Agreements

Summary

House Bill 838, titled 'State Board of Pharmacy – Prescriber–Pharmacist Agreements', authorizes licensed certified midwives to enter into therapy management contracts and modifies the existing framework for prescriber-pharmacist agreements. The bill repeals the requirement for authorized prescribers to submit these agreements to the health occupations board, allowing pharmacists to enter into agreements that enable them to treat opioid use disorders with controlled dangerous substances. Additionally, it mandates that pharmacists must request data from the Prescription Drug Monitoring Program before initiating or modifying such therapy.

Impact

The bill significantly impacts the regulation of pharmacy practices in Maryland by expanding the scope of practice for pharmacists and allowing certified midwives to participate in therapy management. This change aims to enhance the treatment of opioid use disorders by enabling pharmacists to provide necessary drug therapy under specific protocols, thereby addressing public health concerns related to opioid addiction. The repeal of the submission requirement streamlines the process for prescribers and pharmacists, potentially increasing collaboration in patient care.

Sentiment

The general sentiment surrounding HB 838 appears to be supportive, as it addresses critical issues related to opioid treatment and expands the roles of healthcare providers. Although there are no recorded votes or detailed committee discussions available, the approval by the Governor suggests a consensus on the importance of improving access to treatment for opioid use disorders.

Contention

While the bill has garnered support for its potential to improve healthcare delivery, there may be concerns regarding the oversight of pharmacists in prescribing controlled substances. Some stakeholders may worry about the adequacy of training and monitoring required for pharmacists to safely manage opioid therapy, as well as the implications for patient safety and the potential for misuse of prescribed medications.

Companion Bills

No companion bills found.

Similar Bills

No similar bills found.